Type 2 diabetes in the child and adolescent

Pediatric Diabetes

Volumn 15, Issue SUPPL.20, 2014, Pages 26-46

  Zeitler, Phil ^a   Fu, Junfen ^b   Tandon, Nikhil ^c   Nadeau, Kristen ^a   Urakami, Tatsuhiko ^d   Barrett, Timothy ^e   Maahs, David ^f  

^a CHILDREN S HOSPITAL COLORADO   (United States)

^b CHILDREN S HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^d NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^f UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

Guidelines; ISPAD; Type 2 diabetes

Indexed keywords

ADOLESCENT; AUTOIMMUNITY; CHILD; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIFFERENTIAL DIAGNOSIS; EVIDENCE BASED MEDICINE; FAMILY; HEALTH CARE ORGANIZATION; HUMAN; IMMUNOLOGY; INFANT; INSULIN RESISTANCE; INTERNATIONAL COOPERATION; MEDICINE; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PATIENT EDUCATION; PEDIATRICS; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PREDIABETIC STATE; PRESCHOOL CHILD; SELF CARE; TRENDS;

ADOLESCENT; ADOLESCENT MEDICINE; AUTOIMMUNITY; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; EVIDENCE-BASED MEDICINE; FAMILY; HUMANS; INDIVIDUALIZED MEDICINE; INFANT; INSULIN RESISTANCE; INTERNATIONAL AGENCIES; PATIENT EDUCATION AS TOPIC; PEDIATRICS; PREDIABETIC STATE; SELF CARE; SOCIETIES, SCIENTIFIC;

EID: 84906840682     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12179     Document Type: Article

References (149)

1. Rosenbloom AL, Young RS, Joe JR, Winter W. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999: 22: 345-354.
2. American Diabetes Association. Type 2 diabetes in children and adolescents: consensus conference report. Diabetes Care 2000: 23: 381-389.
3. Duncan GE. Prevalence of diabetes and impaired fasting glucose levels among US adolescents: National Health and Nutrition Examination Survey. Arch Pediatr Adolesc Med 1999-2002: 2006: 523-528.
4. Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr 2005: 146: 693-700.
5. Drake AJ, Smith A, Betts PR, Crowne EC, Sheild JP. Type 2 diabetes in obese white children. Arch Dis Child 2002: 86: 207-208.
6. Kitagawa T, Owada M, Urakami T, Yamauchi K. Increased incidence of non-insulin dependent diabetes mellitus among Japanese school children correlates with an increased intake of animal protein and fat. Clin Pediatr (Phila) 1998: 37: 111-115.
7. Ehtisham S, Hattersley AT, Dunger DB, Barrett TG, Group BSfPEaDCT. First UK survey of paediatric type 2 diabetes and MODY. Arch Dis Child 2004: 89: 526-529.
8. The SEARCH for Diabetes in Youth Study Group. Incidence of diabetes in youth in the United States. JAMA 2007: 297: 2716-2724.
9. Kadiki OA, Reddy MR, Marzouk AA. Incidence of insulin-dependent diabetes (IDDM) and non-insulin-dependent diabetes (NIDDM) (0-34 years at onset) in Benghazi, Libya. Diabetes Res Clin Pract 1996: 32: 165-173.
10. Chan JC, Cheung CK, Swaminathan R, Nicholls MG, Cockram CS. Obesity albuminuria, and hypertension among Hong Kong Chinese with non-insulin dependent diabetes mellitus (NIDDM). Postgrad Med J 1993: 69: 204-210.
11. Wei JN, Sung FC, Li CY et al. Low birth weight and high birth weight in infants are both an increased risk to have type 2 diabetes among schoolchildren in Taiwan. Diabetes Care 2003: 26: 343-348.
12. Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Type 2 diabetes in Asian-Indian urban children. Diabetes Care 2003: 2003: 1022-1023.
13. Sayeed MA, Hunsain MZ, Banu A, Mak R, Azad Khan AK. Prevalence of diabetes in a suburban population of Bangladesh. Diabetes Res Clin Pract 1997: 34: 149-155.
14. Braun B, Zimmerman MB, Kretchmer N, Spargo RM, Smith RM, Gracey M. Risk factors for diabetes and cardiovascular disease in young Australian aborigines: a 5-year follow-up study. Diabetes Care 1996: 19: 472-479.
15. McGrath NM, Parker GN, Dawson P. Early pre-sensation of type 2 diabetes mellitus in young New Zealand Maori. Diabetes Res Clin Pract 1999: 43: 205-209.
16. Eppens MC, Craig ME, Jones TW et al. Type 2 diabetes in youth from the Western Pacific region: glycemic control, diabetes care and complications. Curr Med Res Opin 2006: 22: 1013-1020.
17. Sugihara S, Sasaki N, Kohno H et al. Survey of current medical treatments for childhood-onset type 2 diabetes mellitus in Japan. Clin Pediatr Endocrinol 2005: 14: 65-75.
18. Rosenbloom AL, Silverstein JH, Amemiya S, Zeitler P, Klingensmith GJ. Type 2 diabetes in children and adolescents. Pediatr Diabetes 2009: 10 (Suppl 12): 17-32.
19. Druet C, Tubiana-Rufi N, Chevenne D, Rigal O, Polak M, Levy-Marchal C. Characterization of insulin secretion and resistance in type 2 diabetes of adolescents. J Clin Endocrinol Metab 2006: 91: 401-404.
20. Miller J, Silverstein JH, Rosenbloom AL. Type 2 diabetes in the child and adolescent. In: Lifshitz F (ed) Pediartric Endocrinology: fifth edition, volume 1. New York, Marcel Dekker 2007: pp 169-188.
21. United Kingdom Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998: 352: 837-853.
22. TODAY Study Group, Zeitler P, Hirst K et al. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med 2012: 366: 2247-2256.
23. TODAY Study Group. Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care 2013: 36: 1735-1741.
24. Plourde G. Impact of obesity on glucose and lipid profiles in adolescents at different age groups in relation to adulthood. BMC Fam Pract 2002: 3: 18.
25. American Diabetes Association. Standards of medical care in diabetes - 2014. Diabetes Care 2014: 37 (Suppl 1): S14-S80.
26. Libman IM, Barinas-Michell E, Bartucci A, Robertson R, Arslanian S. Reproducibility of the oral glucose tolerance test in overweight children. J Clin Endocrinol Metab 2008: 93: 4231-4237.
27. Kapadia CR. Are the ADA hemoglobin A1c criteria relevant for the diagnosis of type 2 diabetes in youth? Curr Diab Rep 2013: 13: 51-55.
28. Umpaichitra V, Banerji MA, Castells S. Autoantibodies in children with type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2002: 15: 525-530.
29. Reinhard T, Schober E, Weigand S, Thon A, Holl R, Group obotD-WS. β-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification? Arch Dis Child 2006: 91: 473-477.
30. Landin-Olsson M. Latent autoimmune diabetes in adults. Ann N Y Acad Sci 2002: 958: 112-116.
31. Winter WE, Maclaren NK, Riley WJ, Clarke DW, Kappy MS, Spillar RP. Maturity onset diabetes of youth in black Americans. N Engl J Med 1987: 316: 112-116.
32. Klingensmith GJ, Laffel L, Pyle L et al. The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype. Diabetes Care 2010: 33: 1970-1975.
33. Turner R, Stratton I, Horton V et al. UKPDS 25: autoantibodies to islet cell cytoplasm and glutamic acid decarboxylase for pre-diction of insulin requirement in type 2 diabetes. Lancet 1997: 350: 1288-1293.
34. Laffel L, Chang N, Grey M et al. Metformin monotherapy in youth with recent onset type 2 diabetes: experience from the prerandomization run-in phase of the TODAY study. Pediatr Diabetes 2012: 13: 369-375.
35. Copeland KC, Zeitler P, Geffner M et al. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. J Clin Endocrinol Metab 2011: 96: 159-167.
36. The Epidemiology of Diabetes Interventions and Complications Study Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003: 290: 2159-2167.
37. Urakami T, Kuwabara R, Habu M et al. Clinical characteristics of non-obese children with type 2 diabetes mellitus without involvement of β-cell autoimmunity. Diabetes Res Clin Pract 2013: 99: 105-111.
38. Rosenbloom AL. Obesity, insulin resistance, beta cell autoimmunity, and the changing clinical epidemiology of childhood diabetes. Diabetes Care 2003: 26: 2954-2956.
39. Zeitler P, Haqq A, Rosenbloom A, Glaser N, Lawson Wilkins Pediatric Endocrine Society. Hyperglycemic hyperosmolar syndrome in children: pathophysiological considerations and suggested guidelines for treatment. J Pediatr 2011: 158: 9-14.
40. Nadeau KJ, Regensteiner JG, Bauer TA et al. Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function. J Clin Endocrinol Metab 2010: 95: 513-521.
41. Nadeau KJ, Zeitler PS, Bauer TA et al. Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity. J Clin Endocrinol Metab 2009: 94: 3682-3685.
42. Cali AMC, Bonadonna RC, Trombetta M, Weiss R, Caprio S. Metabolic abnormalities underlying the different prediabetic phenotypes in obese adolescents. J Clin Endocrinol Metab 2008: 93: 1767-1773.
43. Weiss R, Taksali SE, Tamborlane WV, Burgert TS, Savoye M, Caprio S. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care 2005: 28: 902-909.
44. Group TS. Retinopathy in youth with type 2 diabetes participating in the TODAY clinical trial. Diabetes Care 2013: 36: 1772-1774.
45. Group TS. Lipid and inflammatory cardiovascular risk worsens over 3 years in youth with type 2 diabetes. Diabetes Care 2013: 36: 1758-1764.
46. Aslander-van Vliet E, Smart C, Waldron S. Nutritional management in childhood and adolescent diabetes. Pediatr Diabetes 2007: 8: 323-339.
47. Copeland KC, Silverstein J, Moore KR et al. Management of newly diagnosed type 2 Diabetes Mellitus (T2DM) in children and adolescents. Pediatrics 2013: 131: e648-e664.
48. Schellenberg ES, Dryden DM, Vandermeer B, Ha C, Korownyk C. Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med 2013: 159: 543-551.
49. Yoon U, Kwok LL, Magkidis A. Efficacy of lifestyle interventions in reducing diabetes incidence in patients with impaired glucose tolerance: a systematic review of randomized controlled trials. Metabolism 2013: 62: 303-314.
50. Lee S, Kim Y. Effects of exercise alone on insulin sensitivity and glucose tolerance in obese youth. Diabetes Metab J 2013: 37: 225-232.
51. Barlow SE, Committee E. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 2007: 120 (Suppl 4): S164-S192.
52. Fitch C, Keim KS, Academy of Nutrition and Dietetics. Position of the academy of nutrition and dietetics: use of nutritive and nonnutritive sweeteners. J Acad Nutr Diet 2012: 112: 739-758.
53. Slavin JL, Lloyd B. Health benefits of fruits and vegetables. Adv Nutr 2012: 3: 506-516.
54. American Diabetes A. Standards of medical care in diabetes - 2012. Diabetes Care 2012: 35 (Suppl 1): S11-S63.
55. Dhuper S, Buddhe S, Patel S. Managing cardiovascular risk in overweight children and adolescents. Paediatr Drugs 2013: 15: 181-190.
56. Jensen MD, Ryan DH, Apovian CM et al. AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 2014: 63: 2985-3023.
57. Chahal H, Fung C, Kuhle S, Veugelers PJ. Availability and night-time use of electronic entertainment and communication devices are associated with short sleep duration and obesity among Canadian children. Pediatr Obes 2013: 8: 42-51.
58. Lane A, Harrison M, Murphy N. Screen time increases risk of overweight and obesity in active and inactive 9 year old Irish children: a cross sectional analysis. J Phys Act Health 2013 Jun 24 Epub ahead of print.
59. Taveras EM, McDonald J, O'Brien A et al. Healthy Habits, Happy Homes: methods and baseline data of a randomized controlled trial to improve household routines for obesity prevention. Prev Med 2012: 55: 418-426.
60. Haines J, McDonald J, O'Brien A et al. Healthy Habits, Happy Homes: randomized trial to improve household routines for obesity prevention among preschool-aged children. JAMA Pediatr 2013: 167: 1072-1079.
61. Robinson TM. Reducing children's television viewing to prevent obesity. A randomized controlled trial. JAMA 1999: 82: 1561-1567.
62. Mays D, Streisand R, Walker LR, Prokhorov AV, Tercyak KP. Cigarette smoking among adolescents with type 1 diabetes: strategies for behavioral prevention and intervention. J Diabetes Complications 2012: 26: 148-153.
63. Group TAS. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 2010: 362: 1563-1574.
64. Bretzel RG, Number U, Landgraf W, Owens DR, Bradley C, Linn T. Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial. Lancet 2008: 371: 1073-1084.
65. The TODAYT Study Group. Safety and tolerability of the treatment of youth-onset type 2 diabetes. Diabetes Care 2013: 36: 1765-1771.
66. Gottschalk M, Vlajnic A, Danne T, Cara JF. Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study. Diabetes Care 2007: 30: 790-794.
67. Lincoff AM, Wolski K, Nicholls SJ, Nissen SE. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA 2007: 298: 1180-1188.
68. Singh S, Loke YK, Furberg CD. Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA 2007: 298: 1189-1195.
69. Singh RK, Perros P, Frier BM. Hospital management of diabetic ketoacidosis: are clinical guidelines implemented effectively? Diabet Med 1997: 14: 482-486.
70. Chiasson J, Josse R, Hunt J et al. The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial. Ann Intern Med 1994: 121: 928-935.
71. Inge TH, Zeller M, Garcia VF, Daniels SR. Surgical approach to adolescent obesity. Adolesc Med Clin 2004: 15: 429-453.
72. Michalsky MP, Inge TH, Teich S et al. Adolescent bariatric surgery program characteristics: The Teen Longitudinal Assessment of Bariatric Surgery (Teen-LABS) study experience. Semin Pediatr Surg 2014: 23: 5-10.
73. Reaven G. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, different goals. Endocrinol Metab Clin North Am 2004: 33: 283-303.
74. Banerjee S, Raghavan S, Wasserman EJ, Lin-Der BL, Saenger P, Dimartino-Nardi J. Hormonal findings in African American and Caribbean Hispanic girls with premature adrenarche: implications for polycystic ovarian syndrome. Pediatrics 1998: 102: E35.
75. Ibanez L, Potau N, Marcos MV, Dezegher F. Exaggerated adrenarche and hyperinsulinism in adolescent girls born small for gestational age. J Clin Endocrinol Metab 1999: 84: 4739-4741.
76. Dabelea D, Crume T. Maternal environment and the transgenerational cycle of obesity and diabetes. Diabetes 2011: 60: 1849-1855.
77. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001: 285: 2486-2497.
78. Ford ES, Li C. Defining the metabolic syndrome in children and adolescents: will the real definition please stand up? J Pediatr 2008: 152: 160-164.
79. Zimmet P, Alberti G, Kaufman F et al. The metabolic syndrome in children and adolescents. Lancet 2007: 369: 2059-2061.
80. Laurson KR, Welk GJ, Eisenmann JC. Diagnostic performance of BMI percentiles to identify adolescents with metabolic syndrome. Pediatrics 2014: 133: e330-e338.
81. Kirpichnikov D, Sowers JR. Diabetes mellitus and diabetes-associated vascular disease. Trends Endocrinol Metab 2001: 12: 225-230.
82. Laakso M. Lipids in type 2 diabetes. Semin Vasc Med 2002: 2: 59-66.
83. Goldberg IJ. Diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab 2001: 86: 965-971.
84. Donaghue KC, Francesco C, Trotta D, Allgrove J, Dahl-Jorgensen K. Microvascular and macrovascular complications. Pediatr Diabetes 2007: 8: 163-170.
85. Wabitsch M, Hauner H, Hertrampf M et al. Type II diabetes and impaired glucose regulation in Caucasian children and adolescents with obesity living in Germany. Int J Obes 2004: 28: 307-313.
86. Wiegand S, Raile K, Reinehr T et al. Daily insulin requirement of children and adolescents with type 1 diabetes: effect of age, gender, body mass index and mode of therapy. Eur J Endocrinol 2008: 158: 543-549.
87. Shalitin S, Abrahami M, Lilos P, Phillip M. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary care center in Israel. Int J Obes 2005: 29: 571-578.
88. STOPP-T2D Study Group. Presence of diabetes risk factors in a large US eighth-grade cohort. Diabetes Care 2006: 29: 212-217.
89. Goran MI, Bergman RN, Avila Q et al. Impaired glucose tolerance and reduced β-cell function in overweight Latino children with a positive family history for type 2 diabetes. J Clin Endocrinol Metab 2004: 89: 207-212.
90. Lee S, Bacha F, Gungor N, Arslanian SA. Waist circumference is an independent predictor of insulin resistance in black and white youths. J Pediatr 2006: 148: 188-194.
91. Freedman DS, Khan LK, Dietz WH, Srini-Vasan SR, Berenson GS. Relationship of childhood obesity to coronary heart disease risk factors in adult-hood: the Bogalusa heart study. Pediatrics 2001: 108: 712-718.
92. Berenson GS, Srini-Vasa SR. Cardiovascular risk factors in youth with implications for aging: the Bogalusa Heart Study. Neurobiol Aging 2005: 26: 303-307.
93. Juonala M, Jarvisalo MJ, Maki-Torkko N, Kahonen M, Viikari JS, Raitakari OT. Risk factors identified in childhood and decreased carotid artery elasticity in adulthood: the Cardiovascular Risk in Youth Finns Study. Circulation 2005: 112: 1486-1493.
94. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Low-grade systemic inflammation in overweight children. Pediatrics 2001: 107: e13.
95. Marcus MD, Foster GD, El Ghormli L et al. Shifts in BMI category and associated cardiometabolic risk: prospective results from HEALTHY study. Pediatrics 2012: 129: e983-e991.
96. Williams CL, Hayman LL, Daniels SR et al. Cardiovascular health in childhood: A statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2002: 106: 143-160.
97. UKPDS Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS. BMJ 1998: 317: 703-713.
98. Eppens MC, Craig ME, Cusumano J et al. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care 2006: 29: 1300-1306.
99. West NA, Hamman RF, Mayer-Davis EJ et al. Cardiovascular risk factors among youths with and without type 2 diabetes: differences and possible mechanisms. Diabetes Care 2009: 32: 175-180.
100. Mayer-Davis EJ, Ma B, Lawson A et al. Cardiovascular disease risk factors in youth with type 1 and type 2 diabetes: implications of a factor analysis of clustering. Metab Syndr Relat Disord 2009: 7: 89-95.
101. Wierzbicki AS, Nimmo L, Feher MD, Cox A, Foxton J, Lant AF. Association of angiotensin-converting enzyme DD genotype with hypertension in diabetes. J Hum Hypertens 1995: 9: 671-673.
102. Batisky DL. What is the optimal first-line agent in children requiring antihypertensive medication? Curr Hypertens Rep 2012: 14: 603-607.
103. National High Blood Pressure Education Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004: 114 (2 Suppl 4th Report): 555-576.
104. Blowey DL. Update on the pharmacologic treatment of hypertension in pediatrics. J Clin Hypertens 2012: 14: 383-387.
105. Lurbe E, Cifkova R, Cruickshank JK et al. Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens 2009: 27: 1719-1742.
106. Ettinger LM, Freeman K, DiMartino-Nardi JR, Flynn JT. Microalbuminuria and abnormal ambulatory blood pressure in adolescents with type 2 diabetes mellitus. J Pediatr 2005: 147: 67-73.
107. Fagot-Campagna A, Knowler WC, Pettit DJ. Type 2 diabetes in Pima Indian children: cardiovascular risk factors at diagnosis and 10 years later. Diabetes 1998: 47 (Suppl 1): A155.
108. Sellers E, Young G, Dean H. Dyslipidemia and other cardiovascular risk factors in a Canadian First Nation pediatric population with type 2 diabetes mellitus. Pediatr Diabetes 2007: 8: 384-390.
109. Dart AB, Sellers EA, Martens PJ, Brownell MD, Dean HJ. High burden of kidney disease in youth-onset type 2 diabetes. Diabetes Care 2012: 35: 1265-1271.
110. Yokohama H, Okudaira M, Otani T et al. High incidence of diabetic nephropathy in early-onset Japanese NIDDM patients. Diabetes Care 1998: 21: 1080-1085.
111. Yokohama H, Okudaira M, Otani T et al. Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan. Kidney Int 2000: 58: 302-311.
112. Rodriguez BL, Fujimoto WY, Mayer-Davis EJ et al. Prevalence of cardiovascular disease risk factors in U.S. children and adolescents with diabetes: the SEARCH for diabetes in youth study. Diabetes Care 2006: 29: 1891-1896.
113. Springer SC, Silverstein J, Copeland K et al. Management of type 2 diabetes mellitus in children and adolescents. Pediatrics 2013: 131: e648-e664.
114. Kavey RE, Allada V, Daniels SR et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2006: 114: 2710-2738.
115. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents, National Heart Lung and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011: 128 (Suppl 5): S213-S256.
116. Flint A, Arslanian S. Treatment of type 2 diabetes in youth. Diabetes Care 2011: 34 (Suppl 2): S177-S183.
117. Wadwa RP, Urbina EM, Anderson AM et al. Measures of arterial stiffness in youth with type 1 and type 2 diabetes: the SEARCH for diabetes in youth study. Diabetes Care 2010: 33: 881-886.
118. Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet 2007: 370: 685-697.
119. Amini M, Horri N, Farmani M et al. Prevalence of polycystic ovary syndrome in reproductive-aged women with type 2 diabetes. Gynecol Endocrinol 2008: 24: 423-427.
120. Shafiee MN, Khan G, Ariffin R et al. Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: could metformin help? Gynecol Oncol 2014: 132: 248-253.
121. Legro RS, Arslanian SA, Ehrmann DA et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2013: 98: 4565-4592.
122. Dean H, Sellers E. Steatohepatitis in children with type 2 diabetes mellitus. Diabetes 2001: 50 (Suppl 2): A378.
123. Newfield R, Schwimmer J. Non alcoholic steatohepatitis in children and adolescents with type 2 diabetes mellitus. Diabetes 2003: 52 (Suppl 1): A4041754.
124. Nadeau KJ, Klingensmith F, Zeitler P. Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase. J Pediatr Gastroenterol Nutr 2005: 41: 94-98.
125. Roberts EA. Non-alcoholic fatty liver disease (NAFLD) in children. Front Biosci 2005: 10: 2306-2318.
126. Hudson OD, Nunez M, Shaibi GQ. Ethnicity and elevated liver transaminases among newly diagnosed children with type 2 diabetes. BMC Pediatr 2012: 12: 174.
127. Sundaram SS, Zeitler P, Nadeau K. The metabolic syndrome and nonalcoholic fatty liver disease in children. Curr Opin Pediatr 2009: 21: 529-535.
128. Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 2013: 5: 1544-1560.
129. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999: 30: 1356-1362.
130. Sinha SK, Shaheen M, Rajavashisth TB, Pan D, Norris KC, Nicholas SB. Association of race/ethnicity, inflammation, and albuminuria in patients with diabetes and early chronic kidney disease. Diabetes Care 2014: 37: 1060-1068.
131. Kastelan S, Tomic M, Gverovic Antunica A, Salopek Rabatic J, Ljubic S. Inflammation and pharmacological treatment in diabetic retinopathy. Mediators Inflamm 2013: 2013.
132. van Greevenbroek MM, Schalkwijk CG, Stehouwer CD. Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences. Neth J Med 2013: 71: 174-187.
133. Montane J, Cadavez L, Novials A. Stress and the inflammatory process: a major cause of pancreatic cell death in type 2 diabetes. Diabetes Metab Syndr Obes 2014: 7: 25-34.
134. Vendrell J, Chacon MR. TWEAK: a new player in obesity and diabetes. Front Immunol 2013: 4: 488.
135. Zhong J, Rao X, Braunstein Z et al. T cell costimulation protects obesity-induced adipose inflammation and insulin resistance. Diabetes 2013: 63: 1289-1302.
136. Lee J. Adipose tissue macrophages in the development of obesity-induced inflammation, insulin resistance and type 2 diabetes. Arch Pharm Res 2013: 36: 208-222.
137. Rice TB, Foster GD, Sanders MH et al. The relationship between obstructive sleep apnea and self-reported stroke or coronary heart disease in overweight and obese adults with type 2 diabetes mellitus. Sleep 2012: 35: 1293-1298.
138. Foster GD, Sanders MH, Millman R, Group SAR. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care 2009: 326: 1017-1019.
139. Shaw JE, Punjabi NM, Wilding JP, Alberti KG, Zimmet PZ, Prevention IDFToEa. Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pract 2008: 8: 2-12.
140. Walders-Abramson N. Depression and quality of life in youth-onset type 2 diabetes mellitus. Curr Diab Rep 2014: 14: 449.
141. Zenlea IS, Mednick L, Rein J, Quinn M, Wolfsdorf J, Rhodes ET. Routine behavioral and mental health screening in young children with type 1 diabetes mellitus. Pediatr Diabetes 2013: Nov 26 Epub ahead of print.
142. Pervanidou P, Chrousos GP. Metabolic consequences of stress during childhood and adolescence. Metabolism 2012: 61: 611-619.
143. Anderson BJ, Edelstein S, Abramson NW et al. Depressive symptoms and quality of life in adolescents with type 2 diabetes: baseline data from the TODAY study. Diabetes Care 2011: 34: 2205-2207.
144. Lawrence JM, Standiford DA, Loots B et al. Prevalence and correlates of depressed mood among youth with diabetes: the SEARCH for diabetes in youth study. Pediatrics 2006: 117: 1348-1358.
145. Dietz WH, Gross WL, Kirkpatrick JA. Blount disease (tibia vara): another skeletal disorder associated with childhood obesity. J Pediatr 1982: 101: 735-737.
146. Loder RT, Aronson DD, Greenfield ML. The epidemiology of bilateral slipped capital femoral epiphysis. A study of children in Michigan. J Bone Joint Surg Am 1993: 75: 1141-1147.
147. Constantino MI, Molyneaux L, Limacher-Gisler F et al. Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes. Diabetes Care 2013: 36: 3863-3869.
148. Rhodes ET, Prosser LA, Hoerger TJ, Ludwig DS, Laffel LM. Estimated morbidity and mortality in adolescents and young adults diagnosed with type 2 diabetes mellitus. Diabet Med 2012: 29: 453-463.
149. Sackett DL, Holland WW. Controversy in detection of disease. Lancet 1965: ii: 357-359.